Helixgate https://validator.w3.org/feed/docs/rss2.html David Reese to retire from Amgen Novel KIR‑CAR T Approach Shows Early Activity Against Solid Tumors BBOT shakes up leadership as RAS competitors get more visibility Novo’s pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloud Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change STAT+: AMA calls for regulatory crackdown on chatbots, wellness AI Endpoints wins Neal Awards for Trump and gene editing coverage, JPM event Across 7 hearings, RFK Jr. talks a new, more moderate MAHA Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’ AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data Gravity Rail raises $2.75M from Redesign Health for AI patient communication AbbVie commits $1.4B to NC plant in its largest-ever single campus investment STAT+: Can Erasca be biotech’s next big thing? We’ll see The next era of diabetes management Sanofi defends Garijo appointment, says it is ‘fully committed’ to immunology STAT+: Will bargain-basement telehealth visits help pharma drive drug scripts? 11 companies hiring in Illinois now STAT+: Publicly, Kennedy embraces a more moderate MAHA Life sciences still falls short on pay equity STAT+: Federal test of AI prior authorization is delaying care for seniors, report says OpenAI’s head of health lays out the AI giant’s healthcare ambitions Brain Astrocytes Form Far-Reaching Connections in Mice AbbVie’s North Carolina $1.4B manufacturing site to finish during Trump’s term STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more FDA issues warning letter after GLP-1 manufacturer refuses inspectors access Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work Live: Robert F. Kennedy Jr. testifies before Senate HELP committee Pharma-backed petition calls on FDA to reform release of drug rejection letters Viral Contamination Still a Challenge for CGT Industry Revolution drug shows promise in early pancreatic cancer Nektar’s $325M offering; Maze stock rises; Merck deal rumors; BMS layoffs Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategy Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors Tipping the genomic scales: Preparing for the integrated multiomics era STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more The 4 biggest hiring mistakes biopharma executives keep making Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decision Lilly exits Rigel alliance, adding to RIPK1 scrap heap Lilly, Novo dip as proposed Medicare coverage for GLP-1 pilot thrown off balance Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot STAT+: CMS, FDA team up to fast-track reimbursement for breakthrough devices Moderna continues bird flu vax study, but limits work in the U.S. Merck steps up as ‘meaningful competitor’ to Gilead with HIV pill approval Antigen‑Stabilized Nanobody Probes Enable On‑Demand, Multicolor Protein Imaging Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush Home